Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sacco

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Future Oncology (London, England)|June 8, 2017
Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017Rodolfo Sacco, Aurora Mirabile, Luca Giacomelli, et al.
Hepato-Gastroenterology|June 30, 2010
Entecavir for hepatitis B virus flare treatment in patients with Crohn's diseaseRodolfo Sacco, Marco Bertini, Giampaolo Bresci, et al.
World Journal of Gastroenterology|November 19, 2010
Endotics system vs colonoscopy for the detection of polypsEmanuele Tumino, Rodolfo Sacco, Marco Bertini, et al.
European Journal of Clinical Investigation|February 12, 2025
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysisAndrea Pasta, Antonio Facciorusso, Maria Corina Plaz Torres, et al.
Future Oncology (London, England)|June 21, 2014
EASL HCC summit: liver cancer managementRodolfo Sacco, Gennaro Gadaleta-Caldarola, Giovanni Galati, et al.
Cancer Letters|August 5, 2014
Circulating TGF-β1-related biomarkers in patients with hepatocellular carcinoma and their association with HCC staging scoresFrancesco Dituri, Gabriella Serio, Doriana Filannino, et al.
Life (Basel, Switzerland)|February 27, 2026
New Treatment Options for MASLD Patients with Type 2 DiabetesAndrea Mega, , Chiara Turri, et al.
Oncology|May 8, 2014
Identification of responders to sorafenib in hepatocellular carcinoma: is tumor volume measurement the way forward?Irene Bargellini, Alessandra Scionti, Valeria Mismas, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenibGiuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature reviewAntonio Facciorusso, Marco Bertini, Michele Bertoni, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Future Oncology (London, England)|June 8, 2017
Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017Rodolfo Sacco, Aurora Mirabile, Luca Giacomelli, et al.
Hepato-Gastroenterology|June 30, 2010
Entecavir for hepatitis B virus flare treatment in patients with Crohn's diseaseRodolfo Sacco, Marco Bertini, Giampaolo Bresci, et al.
World Journal of Gastroenterology|November 19, 2010
Endotics system vs colonoscopy for the detection of polypsEmanuele Tumino, Rodolfo Sacco, Marco Bertini, et al.
European Journal of Clinical Investigation|February 12, 2025
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysisAndrea Pasta, Antonio Facciorusso, Maria Corina Plaz Torres, et al.
Future Oncology (London, England)|June 21, 2014
EASL HCC summit: liver cancer managementRodolfo Sacco, Gennaro Gadaleta-Caldarola, Giovanni Galati, et al.
Cancer Letters|August 5, 2014
Circulating TGF-β1-related biomarkers in patients with hepatocellular carcinoma and their association with HCC staging scoresFrancesco Dituri, Gabriella Serio, Doriana Filannino, et al.
Life (Basel, Switzerland)|February 27, 2026
New Treatment Options for MASLD Patients with Type 2 DiabetesAndrea Mega, , Chiara Turri, et al.
Oncology|May 8, 2014
Identification of responders to sorafenib in hepatocellular carcinoma: is tumor volume measurement the way forward?Irene Bargellini, Alessandra Scionti, Valeria Mismas, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenibGiuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature reviewAntonio Facciorusso, Marco Bertini, Michele Bertoni, et al.
Pageof 17